S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
NASDAQ:EYE

National Vision Stock Forecast, Price & News

$63.53
+4.11 (+6.92 %)
(As of 10/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$60.26
$63.63
50-Day Range
$53.75
$63.53
52-Week Range
$40.00
$63.63
Volume796,605 shs
Average Volume649,233 shs
Market Capitalization$5.20 billion
P/E Ratio36.51
Dividend YieldN/A
Beta1.73
30 days | 90 days | 365 days | Advanced Chart
Receive EYE News and Ratings via Email

Sign-up to receive the latest news and ratings for National Vision and its competitors with MarketBeat's FREE daily newsletter.


National Vision logo

About National Vision

National Vision Holdings, Inc. engages in the retail of optical products. It operates through the following segments: Owned and Host, Legacy, and Corporate/Other. The Owned and Host segment consists of America's Best and Eyeglass World brands. The Legacy segment involves operations of, and supplies inventory and lab processing services. The Corporate/Other segment comprises of the results of operations of the other operating segments and corporate overhead support. The company was founded in 1990 and is headquartered in Duluth, GA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Ophthalmic goods
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:EYE
Employees
12,792
Year Founded
N/A

Sales & Book Value

Annual Sales
$1.71 billion
Cash Flow
$2.44 per share
Book Value
$11.19 per share

Profitability

Net Income
$36.28 million

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$5.20 billion
Next Earnings Date
11/4/2021 (Estimated)
Optionable
Optionable

MarketRank

Overall MarketRank

1.36 out of 5 stars

Medical Sector

1111th out of 1,361 stocks

Ophthalmic Goods Industry

5th out of 5 stocks

Analyst Opinion: 1.3Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -












National Vision (NASDAQ:EYE) Frequently Asked Questions

Is National Vision a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for National Vision in the last twelve months. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" National Vision stock.
View analyst ratings for National Vision
or view top-rated stocks.

What stocks does MarketBeat like better than National Vision?

Wall Street analysts have given National Vision a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but National Vision wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is National Vision's next earnings date?

National Vision is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for National Vision
.

How were National Vision's earnings last quarter?

National Vision Holdings, Inc. (NASDAQ:EYE) posted its quarterly earnings data on Thursday, August, 12th. The company reported $0.48 EPS for the quarter, beating the consensus estimate of $0.19 by $0.29. The company earned $549.49 million during the quarter, compared to analyst estimates of $494.70 million. National Vision had a trailing twelve-month return on equity of 17.77% and a net margin of 7.33%.
View National Vision's earnings history
.

How has National Vision's stock price been impacted by Coronavirus (COVID-19)?

National Vision's stock was trading at $31.66 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, EYE stock has increased by 100.7% and is now trading at $63.53.
View which stocks have been most impacted by COVID-19
.

What guidance has National Vision issued on next quarter's earnings?

National Vision issued an update on its FY 2021 earnings guidance on Thursday, September, 9th. The company provided EPS guidance of $1.280-$1.330 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.100. The company issued revenue guidance of $2.01 billion-$2.06 billion, compared to the consensus revenue estimate of $2.01 billion.

What price target have analysts set for EYE?

7 brokers have issued twelve-month price targets for National Vision's stock. Their forecasts range from $42.00 to $70.00. On average, they expect National Vision's stock price to reach $56.00 in the next twelve months. This suggests that the stock has a possible downside of 11.9%.
View analysts' price targets for National Vision
or view top-rated stocks among Wall Street analysts.

Who are National Vision's key executives?

National Vision's management team includes the following people:
  • L. Reade Fahs, Chief Executive Officer & Director (LinkedIn Profile)
  • Patrick R. Moore, Chief Financial Officer & Senior Vice President
  • Alex Louw, Chief Medical Officer & Senior Vice President
  • Ravi Acharya, Chief Technology Officer & Senior Vice President
  • Jared Brandman, Secretary, Senior Vice President & General Counsel (LinkedIn Profile)

What is L. Reade Fahs' approval rating as National Vision's CEO?

243 employees have rated National Vision CEO L. Reade Fahs on Glassdoor.com. L. Reade Fahs has an approval rating of 97% among National Vision's employees. This puts L. Reade Fahs in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of National Vision's key competitors?

What other stocks do shareholders of National Vision own?

When did National Vision IPO?

(EYE) raised $300 million in an initial public offering (IPO) on Thursday, October 26th 2017. The company issued 15,800,000 shares at a price of $18.00-$20.00 per share. BofA Merrill Lynch, Goldman Sachs, Citigroup, KKR, Morgan Stanley, Jefferies, UBS Investment Bank and Wells Fargo Securities served as the underwriters for the IPO and Guggenheim Securities, Mizuho Securities and Macquarie Capital were co-managers.

What is National Vision's stock symbol?

National Vision trades on the NASDAQ under the ticker symbol "EYE."

Who are National Vision's major shareholders?

National Vision's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Hodges Capital Management Inc. (0.15%). Company insiders that own National Vision stock include Jared Brandman, L Reade Fahs, Melissa Rasmussen, Mfn Partners, Lp, Patrick R Moore and Thomas V Taylor.
View institutional ownership trends for National Vision
.

Which institutional investors are buying National Vision stock?

EYE stock was bought by a variety of institutional investors in the last quarter, including Hodges Capital Management Inc.. Company insiders that have bought National Vision stock in the last two years include Mfn Partners, Lp, and Thomas V Taylor.
View insider buying and selling activity for National Vision
or or view top insider-buying stocks.

How do I buy shares of National Vision?

Shares of EYE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is National Vision's stock price today?

One share of EYE stock can currently be purchased for approximately $63.53.

How much money does National Vision make?

National Vision has a market capitalization of $5.20 billion and generates $1.71 billion in revenue each year. The company earns $36.28 million in net income (profit) each year or $0.88 on an earnings per share basis.

How many employees does National Vision have?

National Vision employs 12,792 workers across the globe.

What is National Vision's official website?

The official website for National Vision is www.nationalvision.com.

Where are National Vision's headquarters?

National Vision is headquartered at 2435 COMMERCE AVENUE BLDG. 2200, DULUTH GA, 30096.

How can I contact National Vision?

National Vision's mailing address is 2435 COMMERCE AVENUE BLDG. 2200, DULUTH GA, 30096. The company can be reached via phone at (770) 822-3600 or via email at [email protected].


This page was last updated on 10/16/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.